Event registration | PRIME Oncology

Advances and Updates in Adjuvant Therapy for Resectable NSCLC

Corey Langer, MD, FACP, Mark Socinski, MD, and Johan Vansteenkiste, MD, PhD, in a roundtable discussion, review updated clinical information regarding adjuvant therapy for treatment of resectable non-small cell lung cancer with a focus on the future of immunotherapy.


CHAIR: Corey J. Langer, MD, FACP University of Pennsylvania, Philadelphia, Pennsylvania, United States	Mark A. Socinski, MD University of North Carolina, Chapel Hill, North Carolina, United States	Johan F. Vansteenkiste, MD, PhD University Hospital Gasthuisberg, Leuven, Belgium

This activity is supported by an educational grant from GlaxoSmithKline.

Please enter your Email address and click "Next" to proceed to the next page.

If your Email address is found in our system, we will retrieve your information for verification,
if not, we will ask you to fill out registration form.